Multicenter prospective cohort study on colorectal adenoma recurrence and malignant transformation risk based on integrative medicine: a study protocol

基于整合医学的结直肠腺瘤复发和恶性转化风险的多中心前瞻性队列研究:一项研究方案

阅读:1

Abstract

INTRODUCTION: Colorectal adenoma (CRA), the main precursor of colorectal cancer (CRC), has a high recurrence rate (5-year cumulative: 48 - 68%) and a malignant transformation risk (0.2 - 0.5%). Traditional Chinese Medicine (TCM) provides a potential method to improve risk assessment and prevention. Based on TCM theories and the characteristics of colorectal adenoma, we hypothesize that an integrated system combining TCM syndromes, constitution types, and modern medical parameters can better predict adenoma recurrence and CRC occurrence. METHODS AND ANALYSIS: This is a multicenter prospective cohort study. A total of 15,000 patients with colonoscopy-confirmed colorectal adenomas will be recruited from 12 tertiary hospitals in China. At baseline, TCM characteristics (syndromes, constitution, tongue and pulse features), endoscopic findings, and biological samples (tongue coating, saliva, stool, blood, tissue) will be collected. The participants will be followed up for 5 years with risk-stratified standardized colonoscopy intervals. The primary outcomes are adenoma recurrence and CRC occurrence. The secondary outcomes include identifying risk factors and developing a predictive model. Multivariable logistic regression, Cox models, and mixed-effects models will be used for data analysis. A comprehensive biobank will be established to support future mechanistic studies. ETHICS AND DISSEMINATION: Ethical approval has been obtained from the Institutional Review Board of the Affiliated Hospital of Nanjing University of Chinese Medicine. Written informed consent will be obtained from all participants, who can withdraw at any time without prejudice. CLINICAL TRIAL REGISTRATION: https://clinicaltrials.gov/study/NCT06136026, identifier NCT06136026.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。